HLS Therapeutics Inc. (HLS.TO)

CAD 3.62

(0.56%)

Inventory Summary of HLS Therapeutics Inc.

  • HLS Therapeutics Inc.'s latest annual inventory in 2023 was 9.53 Million USD , up 7.1% from previous year.
  • HLS Therapeutics Inc.'s latest quarterly inventory in 2024 Q2 was 8.79 Million USD , down -12.78% from previous quarter.
  • HLS Therapeutics Inc. reported annual inventory of 8.9 Million USD in 2022, down -0.26% from previous year.
  • HLS Therapeutics Inc. reported annual inventory of 8.92 Million USD in 2021, down -16.04% from previous year.
  • HLS Therapeutics Inc. reported quarterly inventory of 10.08 Million USD for 2024 Q1, up 5.78% from previous quarter.
  • HLS Therapeutics Inc. reported quarterly inventory of 9.53 Million USD for 2023 FY, up 7.1% from previous quarter.

Annual Inventory Chart of HLS Therapeutics Inc. (2023 - 1996)

Historical Annual Inventory of HLS Therapeutics Inc. (2023 - 1996)

Year Inventory Inventory Growth
2023 9.53 Million USD 7.1%
2022 8.9 Million USD -0.26%
2021 8.92 Million USD -16.04%
2020 10.63 Million USD 417.27%
2019 2.05 Million USD 36.54%
2018 1.5 Million USD 11.15%
2017 1.35 Million USD 12.83%
2016 1.2 Million USD 406.33%
2015 237 Thousand USD 11849900.0%
2014 2.00 USD 100.0%
2013 1.00 USD 0.0%
2012 - USD -100.0%
2011 542.6 Thousand USD 54260400.0%
2010 1.00 USD 0.0%
2009 1.00 USD 0.0%
2008 1.00 USD -50.0%
2007 2.00 USD -100.0%
2006 81.5 Thousand USD -19.1%
2005 100.74 Thousand USD -34.54%
2004 153.89 Thousand USD -23.25%
2003 200.49 Thousand USD 10024800.0%
2002 2.00 USD 0.0%
2001 2.00 USD 199951822.53%
2000 - USD -100.0%
1999 2.07 Million USD 27.49%
1998 1.62 Million USD -31.62%
1997 2.37 Million USD 100.15%
1996 1.18 Million USD 0.0%

Peer Inventory Comparison of HLS Therapeutics Inc.

Name Inventory Inventory Difference
Aurora Cannabis Inc. 186.37 Million CAD 94.885%
Avicanna Inc. 4.54 Million CAD -109.804%
Avant Brands Inc. 28.93 Million CAD 67.053%
Cardiol Therapeutics Inc. -279.87 Thousand CAD 3506.557%
Crescita Therapeutics Inc. 6.12 Million CAD -55.657%
Knight Therapeutics Inc. 91.83 Million CAD 89.618%
MediPharm Labs Corp. 9.89 Million CAD 3.687%
OrganiGram Holdings Inc. 80.95 Million CAD 88.223%
Canopy Growth Corporation 77.29 Million CAD 87.665%
Willow Biosciences Inc. 221 Thousand CAD -4214.027%
Auxly Cannabis Group Inc. 31.42 Million CAD 69.665%